Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie(The Royal Melbourne Hospital), Peter Gibbs(The University of Melbourne)
Cited by 683
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
|Science Translational Medicine|2016|1.5k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
|European Journal of Cancer|2017|293